This inventor holds 3 USPTO granted patents. Top assignee: Smith Kline & French Laboratories Limited. Active years: 1988-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-1990
Title: David Ellis: Innovator in Thyromimetic Compounds
Introduction
David Ellis is a notable inventor based in Letchworth, GB. He has made significant contributions to the field of chemical compounds, particularly those with selective thyromimetic activity. With a total of 3 patents, his work has implications in various scientific and medical applications.
Latest Patents
Among his latest patents, one notable invention is related to pyridyl and pyridazinyl substituted thyronine compounds. This invention focuses on chemical compounds that exhibit selective thyromimetic activity. A specific compound from this invention is 3,5-dibromo-3'-[6-oxo-3(1H)-pyridazinylmethyl]-thyronine. Another patent also addresses chemical compounds with selective thyromimetic activity, reiterating the importance of this area of research.
Career Highlights
David Ellis is associated with Smith Kline & French Laboratories Limited, where he has been able to apply his innovative ideas in a collaborative environment. His work has contributed to advancements in the understanding and application of thyromimetic compounds.
Collaborations
Some of his notable coworkers include Anthony H Underwood and John C Emmett. Their collaboration has likely fostered a productive research atmosphere, leading to significant advancements in their field.
Conclusion
David Ellis stands out as an inventor whose work in chemical compounds has the potential to impact various scientific fields. His contributions to thyromimetic compounds highlight the importance of innovation in medicine and chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile